Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    4201 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 58
    4202 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 61
    4203 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 60
    4204 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 50
    4205 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2020 Experimental Therapy Portugal 18
    4206 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease; Transplantation Failure Hematology 2020 Experimental Therapy Poland 2
    4207 Cord Tissue Allogeneic – Unrelated Guillain-Barré Syndrome Neurology 2020 Experimental Therapy Poland 43
    4208 Cord Tissue Allogeneic – Unrelated Head Injury Neurology 2020 Experimental Therapy Poland 16
    4209 Cord Tissue Allogeneic – Unrelated Hypoxia-Ischemic Encephalopathy (Hie) Neurology 2020 Experimental Therapy Poland 2
    4210 Cord Tissue Allogeneic – Unrelated Hypoxia-Ischemic Encephalopathy (Hie) Neurology 2020 Experimental Therapy Poland 5
    4211 Cord Tissue Allogeneic – Unrelated Hypoxic Encephalopathy; Drug-Resistant Epilepsy Neurology 2020 Experimental Therapy Poland 20
    4212 Cord Tissue Allogeneic – Unrelated Limb Ulceration Dermatology 2020 Experimental Therapy Poland 82
    4213 Cord Tissue Allogeneic – Unrelated Macular Degeneration Ophthalmology 2020 Experimental Therapy Poland 20
    4214 Cord Tissue Allogeneic – Unrelated Muscular Dystrophy Neurology 2020 Experimental Therapy Poland 56
    4215 Cord Tissue Allogeneic – Unrelated Myelomeningocele Neurology 2020 Experimental Therapy Poland 8
    4216 Cord Tissue Allogeneic – Unrelated Myelomeningocele; Arnold-Chiari Malformation Neurology 2020 Experimental Therapy Poland 2
    4217 Cord Tissue Allogeneic – Unrelated Myelomeningocele; Hydrocephalus Neurology 2020 Experimental Therapy Poland 2
    4218 Cord Tissue Allogeneic – Unrelated Myoclonic Epilepsy With Ragged Red Fibers Neurology 2020 Experimental Therapy Poland 23
    4219 Cord Tissue Allogeneic – Unrelated No Bone Adhesion Orthopedy 2020 Experimental Therapy Poland 69
    4220 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 16
    4221 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 66
    4222 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 23
    4223 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 27
    4224 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 31
    4225 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 58
    4226 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2020 Experimental Therapy Poland 41
    4227 Cord Tissue Allogeneic – Unrelated Optic Neuropathy Ophthalmology 2020 Experimental Therapy Poland 41
    4228 Cord Tissue Allogeneic – Unrelated Osteoarthritis Orthopedy 2020 Experimental Therapy Poland 56
    4229 Cord Tissue Allogeneic – Unrelated Other Specific Cartilage Diseases Orthopedics 2020 Experimental Therapy Poland 39
    4230 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System Neurology 2020 Experimental Therapy Poland 4
    4231 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System – Global Development Delay And Microcephaly Neurology 2020 Experimental Therapy Poland 2
    4232 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect Neurology 2020 Experimental Therapy Poland 2
    4233 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect Neurology 2020 Experimental Therapy Poland 5
    4234 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System; Cornelia De Lange Syndrome Neurology 2020 Experimental Therapy Poland 4
    4235 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic Encephalopathy Neurology 2020 Experimental Therapy Poland 4
    4236 Cord Tissue Allogeneic – Unrelated Other Specific Disorders Of The Central Nervous System; Lissencephaly Neurology 2020 Experimental Therapy Poland 6
    4237 Cord Tissue Allogeneic – Unrelated Other Sphingolipidoses; Krabbe’s Leukodystrophy Neurology 2020 Experimental Therapy Poland 4
    4238 Cord Tissue Allogeneic – Unrelated Other Spinal Muscular Atrophy And Related Syndromes; Bulbar Palsy Neurology 2020 Experimental Therapy Poland 0
    4239 Cord Tissue Allogeneic – Unrelated Polyneuropathy Neurology 2020 Experimental Therapy Poland 43
    4240 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2020 Experimental Therapy Poland 33
    4241 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2020 Experimental Therapy Poland 61
    4242 Cord Tissue Allogeneic – Unrelated Soft Tissue Diseases Related To Use, Overload And Pressure Orthopedy 2020 Experimental Therapy Poland 59
    4243 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2020 Experimental Therapy Poland 11
    4244 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2020 Experimental Therapy Poland 1
    4245 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Neurology 2020 Experimental Therapy Poland 33
    4246 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2020 Experimental Therapy Poland 37
    4247 Cord Tissue Allogeneic – Unrelated State After Encephalitis Neurology 2020 Experimental Therapy Poland 3
    4248 Cord Tissue Allogeneic – Unrelated Tendon Injury Orthopedy 2020 Experimental Therapy Poland 29
    4249 Cord Tissue Allogeneic – Unrelated Transplantation Failure; Coexisting Viral Infections Hematology 2020 Experimental Therapy Poland 13
    4250 Cord Tissue Allogeneic Cerebral Palsy – condition after a sudden stoke Neurology 2020 Experimental Therapy Slovakia 63
    4251 Cord Blood Autologous Autism Neurology 2020 Experimental Therapy Poland 0
    4252 Cord Blood Autologous Autism Neurology 2020 Experimental Therapy Germany 9
    4253 Cord Blood Autologous Autism Neurology 2020 Experimental Therapy Germany 5
    4254 Cord Blood Autologous B-Cell Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy UK 5
    4255 Cord Blood Autologous Cerebral Palsy Neurology 2020 Experimental Therapy Poland 2
    4256 Cord Blood Autologous Cerebral Palsy Neurology 2020 Experimental Therapy Poland 2
    4257 Cord Blood Autologous Cerebral Palsy Neurology 2020 Experimental Therapy Poland 2
    4258 Cord Blood Allogeneic – Related Severe Aplastic Anemia Hematology 2020 Standard Therapy Poland 0
    4259 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2020 Standard Therapy Turkey 3
    4260 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2020 Standard Therapy Turkey 3
    4261 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2020 Standard Therapy Turkey 4
    4262 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2020 Standard Therapy Turkey 4
    4263 Cord Blood Allogeneic Cerebral Palsy – condition after a sudden stoke Neurology 2020 Experimental Therapy Slovakia 63
    4264 Cord Blood Autologous Drowning – Persistent Vegetative State, Decortication Neurology 2020 Experimental Therapy Czechia 2
    4265 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia – Relapse Hematology 2020 Standard Therapy Germany 57
    4266 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 69
    4267 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 48
    4268 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 64
    4269 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 72
    4270 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 59
    4271 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 38
    4272 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 63
    4273 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Germany 76
    4274 Bone Marrow Family Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2020 Standard Therapy Germany 61
    4275 Bone Marrow Family Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2020 Standard Therapy Germany 68
    4276 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia Hematology 2020 Standard Therapy Poland 63
    4277 Bone Marrow Family Allogeneic Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 35
    4278 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 71
    4279 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 31
    4280 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 62
    4281 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 59
    4282 Bone Marrow Family Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 67
    4283 Bone Marrow Family Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 63
    4284 Bone Marrow Family Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 70
    4285 Bone Marrow Family Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2020 Standard Therapy Germany 24
    4286 Bone Marrow (Apheresismily donor) Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 68
    4287 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 14
    4288 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 1
    4289 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 52
    4290 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 66
    4291 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 4
    4292 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 15
    4293 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 5
    4294 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 3
    4295 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 62
    4296 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 47
    4297 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 1
    4298 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 16
    4299 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 43
    4300 Bone Marrow Allogeneic Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 9